Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jun;145(6):1673-1680.e11.
doi: 10.1016/j.jaci.2020.01.040. Epub 2020 Feb 6.

RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness

Collaborators, Affiliations
Observational Study

RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness

Tanya Novak et al. J Allergy Clin Immunol. 2020 Jun.

Abstract

Background: Decreased TNF-α production in whole blood after ex vivo LPS stimulation indicates suppression of the Toll-like receptor (TLR)4 pathway. This is associated with increased mortality in pediatric influenza critical illness. Whether antiviral immune signaling pathways are also suppressed in these patients is unclear.

Objectives: We sought to evaluate suppression of the TLR4 and the antiviral retinoic acid-inducible gene-I (RIG-I) pathways with clinical outcomes in children with severe influenza infection.

Methods: In this 24-center, prospective, observational cohort study of children with confirmed influenza infection, blood was collected within 72 hours of intensive care unit admission. Ex vivo whole blood stimulations were performed with matched controls using the viral ligand polyinosinic-polycytidylic acid-low-molecular-weight/LyoVec and LPS to evaluate IFN-α and TNF-α production capacities (RIG-I and TLR4 pathways, respectively).

Results: Suppression of either IFN-α or TNF-α production capacity was associated with longer duration of mechanical ventilation and hospitalization, and increased organ dysfunction. Children with suppression of both RIG-I and TLR4 pathways (n = 33 of 103 [32%]) were more likely to have prolonged (≥7 days) multiple-organ dysfunction syndrome (30.3% vs 8.6%; P = .004) or prolonged hypoxemic respiratory failure (39.4% vs 11.4%; P = .001) compared with those with single- or no pathway suppression.

Conclusions: Suppression of both RIG-I and TLR4 signaling pathways, essential for respective antiviral and antibacterial responses, is common in previously immunocompetent children with influenza-related critical illness and is associated with bacterial coinfection and adverse outcomes. Prospective testing of both pathways may aid in risk-stratification and in immune monitoring.

Keywords: IFN-α; LPS; Polyinosinic:polycytidylic acid; TNF-α; Toll-like receptor 4; critical care; influenza; pediatric; retinoic acid–inducible gene-I; suppression.

PubMed Disclaimer

Conflict of interest statement

COI Statement: Dr. Novak reports grants from NIH and Boston Children’s Hospital during the conduct of the study; Dr. Hall reports grants from NIH during the conduct of the study; personal fees from LaJolla Pharmaceuticals and personal fees from Bristol Myers-Squibb outside the submitted work; Dr. Randolph reports grants from NIH during the conduct of the study and grants from Genentech Inc. outside the submitted work and personal fees from LaJolla Pharmaceuticals; Dr. Junger reports grants from NIH during the conduct of the study; Dr. Mourani reports grants from NIH during the conduct of the study; Dr. Panoskaltsis-Mortari reports grants from NIH during the conduct of the study; Dr. Weiss reports grants from NIGMS outside the submitted work; All other authors have no COI to disclose.

Figures

Figure 1.
Figure 1.. Poly(I:C) -induced IFNα production (a).
Subjects’ IFNα response was characterised into three groups based on ex vivo whole blood IFNα production after 24 hours of unstimulated control incubation (white boxes) and poly(I:C) stimulation (gray boxes). Suppressed subjects had low production of IFNα in both unstimulated controls and poly(I:C)-stimulated blood samples, with a low delta (no significance (NS) vs control), n=56. Peaked subjects had high production of IFNα in both unstimulated controls and poly(I:C) stimulated samples, with a low delta (NS vs control), n=11. Those that Responded had variable IFNα levels in unstimulated controls but were able to produce an increase in their poly(I:C) stimulated blood, with a high delta (p<0.0001 vs control), n=38 based on the Wilcoxon matched-pairs signed rank test. Data represent samples collected ≤72hrs from PICU admission. LPS-induced TNFα production (b). In the LPS stimulated samples categorized as TNFα ≥ or < 200 pg/ml, unstimulated control samples had similar values (p=0.09) while TNFα responses were significantly different (p<0.0001) based on the Mann Whitney U test. Poly(I:C)-induced IFNα response groups with LPS-induced TNFα response data (c). Gray bars represent subjects whose LPS-induced TNFα response was < 200 pg/ml while white bars represent those with a TNFα response ≥ 200 pg/ml. Subjects with Suppressed IFNα were more likely to have a low TNFα response compared to Responders or those with a Peaked IFNα response (Pearson χ2 p<0.0002).
Figure 2.
Figure 2.. Prolonged multiple organ dysfunction in subjects with and without pathway suppression (a).
Subjects who demonstrated dual suppression had the highest incidence of prolonged MODS (defined as MODS or ECMO on/after day 7 of illness or death) or mortality. White areas represent subjects who never experienced MODS which was the smallest in the IFNα and TNFα Suppressed group (p=0.003). Prolonged acute hypoxemic respiratory failure in subjects with and without pathway suppression (b). Subjects who had dual suppression also had the highest incidence of prolonged AHRF (defined as PaO2/FiO2 <200 and remaining on mechanical ventilation on/after day 7) (p=0.001). Pearson χ2 p values represent comparison of MODS status or AHRF (prolonged vs never or resolved) in each stimulation group.

References

    1. Coffin SE, Zaoutis TE, Rosenquist AB, Heydon K, Herrera G, Bridges CB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics. 2007;119(4):740–748. DOI: 10.1542/peds.2006-2679. - DOI - PubMed
    1. Tang BM, Feng CG, McLean AS. Understanding the role of host response in influenza pneumonitis. Intensive Care Med. 2019;45(7):1012–1014. DOI: 10.1007/s00134-019-05582-5. - DOI - PubMed
    1. Trinchieri G. Type I interferon: friend or foe? J Exp Med. 2010;207(10):2053–2063. DOI: 10.1084/jem.20101664. - DOI - PMC - PubMed
    1. Decker T, Muller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol. 2005;5(9):675–687. DOI: 10.1038/nri1684. - DOI - PubMed
    1. Davidson S, Crotta S, McCabe TM, Wack A. Pathogenic potential of interferon alphabeta in acute influenza infection. Nat Commun. 2014;5:3864 DOI: 10.1038/ncomms4864. - DOI - PMC - PubMed

Publication types